Teresa K Chen
Overview
Explore the profile of Teresa K Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1077
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen T, Estrella M, Katz R, Sarnak M, Grams M, Cushman M, et al.
Clin J Am Soc Nephrol
. 2024 Dec;
19(12):1585-1593.
PMID: 39652331
No abstract available.
2.
Chen T, Surapaneni A, Schmidt I, Waikar S, Coresh J, Liu H, et al.
Kidney Med
. 2024 Dec;
6(12):100921.
PMID: 39634331
Rationale & Objective: Individuals with chronic kidney disease (CKD) are at increased risk of morbidity and mortality, particularly as they progress to kidney failure. Identifying circulating proteins that underlie kidney...
3.
Blum M, Surapaneni A, Chang A, Inker L, Chen T, Appel L, et al.
J Gen Intern Med
. 2024 Apr;
39(10):1880-1886.
PMID: 38639831
Background: Early trials of dihydropyridine calcium channel blockers (DCCBs) suggest a detrimental effect on intraglomerular pressure and an association with albuminuria. Objective: We sought to evaluate the associations of DCCB...
4.
Peschard V, Scherzer R, Katz R, Chen T, Bullen A, Campos K, et al.
Kidney360
. 2024 Mar;
5(5):690-697.
PMID: 38472135
No abstract available.
5.
Chen T, Hoenig M, Nitsch D, Grams M
BMJ
. 2023 Dec;
383:e074216.
PMID: 38052474
Chronic kidney disease (CKD) represents a global public health crisis, but awareness by patients and providers is poor. Defined as persistent abnormalities in kidney structure or function for more than...
6.
Srialluri N, Surapaneni A, Schlosser P, Chen T, Schmidt I, Rhee E, et al.
Kidney Med
. 2023 Sep;
5(10):100714.
PMID: 37711886
Rationale & Objective: Proteomics could provide pathophysiologic insight into the increased risk of mortality in patients with chronic kidney disease (CKD). This study aimed to investigate associations between the circulating...
7.
Chen T, Estrella M, Appel L, Surapaneni A, Kottgen A, Obeid W, et al.
Am J Kidney Dis
. 2023 Sep;
83(1):71-78.
PMID: 37690632
Rationale & Objective: Uromodulin (UMOD) is the most abundant protein found in urine and has emerged as a promising biomarker of tubule health. Circulating UMOD is also detectable, but at...
8.
Chen T, Shlipak M
Clin J Am Soc Nephrol
. 2023 Jul;
18(8):988-990.
PMID: 37410991
No abstract available.
9.
Dubin R, Deo R, Ren Y, Lee H, Shou H, Feldman H, et al.
J Appl Lab Med
. 2023 Jan;
8(3):491-503.
PMID: 36705086
Background: We carried out a study of the aptamer proteomic assay, SomaScan V4, to evaluate the analytical and biological variability of the assay in plasma samples of patients with moderate...
10.
Chen T, Coca S, Thiessen-Philbrook H, Heerspink H, Obeid W, Ix J, et al.
Am J Nephrol
. 2023 Jan;
53(11-12):775-785.
PMID: 36630924
Introduction: Diabetes is a leading cause of end-stage kidney disease (ESKD). Biomarkers of tubular health may prognosticate chronic kidney disease (CKD) progression beyond estimated glomerular filtration rate (eGFR) and urine...